AssetMark’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
Other funds holding ARKG
AssetMark's ARKG Position: Q3 2026 in Review
AssetMark held its ARK Genomic Revolution ETF (ARKG) position steady in Q3 2026 at 1 share worth $54. The position accounts for ﹤0.01% of the portfolio, ranked #3715.
AssetMark first reported a position in ARKG in Q4 2020 and has held it in 9 quarters since. The position peaked at $1.74M in Q2 2021. 260 funds tracked by Wall St. Rank hold ARKG as of Q3 2026.
- AssetMark held 1 share of ARK Genomic Revolution ETF worth $54 as of Q3 2026.
- AssetMark left its ARK Genomic Revolution ETF share count unchanged in Q3 2026.
- ARK Genomic Revolution ETF made up ﹤0.01% of AssetMark's portfolio in Q3 2026, its #3715 holding.
- AssetMark first reported a position in ARK Genomic Revolution ETF in Q4 2020 and has held it in 9 quarters since.
- AssetMark's ARK Genomic Revolution ETF position peaked at $1.74M in Q2 2021.
- 260 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2026.
Based on AssetMark's 13F filing for Q3 2026, filed 21 Oct 2026.